Patents Assigned to Enteron, Inc.
  • Immunogenic cancer peptides and uses thereof
    Patent number: 6892140
    Abstract: This invention relates to novel general methods and compositions that provide cancer-specific or highly cancer-associated antigens useful for diagnosis and treatment of cancer.
    Type: Grant
    Filed: November 27, 2000
    Date of Patent: May 10, 2005
    Assignee: Enteron, Inc.
    Inventors: Emanuel Calenoff, Charles Ditlow